The schedule below is for the NET Med Virtual Symposium (Oct. 2-3). To see the Allied Health Workship (Sept. 11), the Early Career Seminar (Sept. 18), and the Future of NETs (Dec. 10) schedules, click here to be taken back to the symposium hompage.

 

October 2-3 | 2020 Virtual Symposium 

Friday, October 2 

9:00 am - 10:00 am EST Virtual Supporter Hall Open 

9:00 am - 10:00 am Poster Exhibits Open 

10:00 am 10:40am - Upcoming Consensus Topics

   Moderator: Emily Bergsland, MD - Welcome, Introductory Remarks

   Speaker: Jennifer Chan, MD, MPH

   Speaker: Thor Halfdanarson, MD

   Audience Participation 

10:45am - 11:25am - NET Medical Session 1: Assessing Response in NETs 

   Moderator: Sukhmani Padda, MD Welcome, Introductory Remarks

   Speaker: Bhavana Konda, MD, MPH Topic: Imaging as a Prognostic Marker

   Speaker: Frank Lin, MD Topic: Imaging Issues in future NET Medical Trials

   Speaker: Jean-Mathieu Beauregard, MD, MSc, FRCPC Topic: Optimal Imaging Post PRRT 

   Audience Participation 

11:30am 12:10pm - Young Investigator Oral Presentations 

   Moderator: David Metz, MD Welcome, Introductory Remarks

Speaker: Chandra Kumar Maharjan, BS - Functional genetic screen to identify drivers of pancreatic neuroendocrine tumor pathogenesis 

Speaker: Catherine Tran, MD - Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling      

Speaker: Sten Myrehaug, MD - A Single-Centre Pilot Study for Radiosensitization of Everolimus with External Beam Radiotherapy for the Treatment of Metastatic Neuroendocrine Liver Metastasis            

Speaker: Daneng Li, MDCross-sectional study assessing the feasibility of using NET VITALS communication tool among patients with neuroendocrine tumors 

   Audience Participation

12:15pm - 12:55pm - NET Medical Session 2: Sequencing of Care in Advanced NETS 

   Moderator: Arvind Dasari, MD Welcome, Introductory Remarks

   Speaker: Ghassan El-Haddad, MD Topic: Liver Directed Therapy  vs PRRT

   Speaker: Marianne Pavel, MD Topic: PRRT vs Chemo for PNET

   Speaker: Heloisa P Soares, MD, PhD Topic: How to treat WD G3

   Audience Participation 

1:00pm - 1:55pm Meet the Experts - Early Career Mentoring Session | Visit Poster Hall or Booth Exhibit Hall | Break 55 minutes

2:00pm - 2:55pm - NET Tumor Board

   Moderator: Bart Rose, MD, MAS Welcome, Introductory Remarks

   Topic: Advanced Ileum Neuroendocrine Tumor - Experts from Around the World

   Case presenter: Callisia N. Clarke, MD, MS

   Panelist: Rodney Pommier, MD; Julie Hallet, MD, M.Sc., FRCSC (Surgery)

   Panelist: Jonathan Strosberg, MD; Jennifer Eads, MD (Med/Onc)

   Panelist: Dan Pryma, MD (Nuc Med) Panelist: Sarah White, MD (IR)

   Audience Participation 

3:00pm - 3:40pm - NET Medical Session 3: Session Topic: Medullary Thyroid Cancer 

   Moderator: Chandrikha Chandrasekharan, MBBS Welcome, Introductory Remarks

   Speaker: James Bibb, PhD Topic: Translational Studies of MTC

   Speaker: Marcia Simpson Brose, MD, PhD Topic: Clinical Trials for MTC 

   Speaker: Julie Ann Sosa, MD, MA, FACS Topic: Surgery for MTC

   Audience Participation

3:45pm - 4:25pm -  Abstracts 1

   Moderator: Dawn Quelle, PhD Welcome, Introductory Remarks

Speaker: Kevin Yang, BS - Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms  

Speaker: Karine Pozo, PhD - The lineage transcription factors ASCL1, NKX2-1, and PROX1 form a regulatory network and control the expression of the ion channel, SCN3A, in small cell lung cancer

Speaker: Po Hien Ear, PhD - A Systematic Workflow to Identify Anti-cancer Drugs Targeting Small Bowel Neuroendocrine Tumors and Neuroendocrine Carcinomas

Speaker: Ume Salma Shaik Amjad, PhD - Efficacy of combined MEK and CDK targeted therapies for pancreatic neuroendocrine tumors

   Audience Participation 

Meet the Experts - Early Career Mentoring Session | Visit Poster Hall or Booth Exhibit Hall | Break live, 55 minutes

5:30pm-7:15pm - NANETS/SNMMI PRRT Workshop: The Practical Perspective on PRRT 

   Moderator: Kimberly Perez, MD Welcome, Introductory Remarks

   Speaker: Josh Mailman Topic: History and Common Misconceptions of PRRT 

   Speaker: Jennifer Pangelinan, BSN, RN, OCN Topic: What the Patients Should Know 

   Speaker: Renuka Iyer, MD Topic: Preparing for Special Cases 

   Speaker: Thor Halfdanarson, MD Topic: Treating Outside NETTER-1 

   Speaker: Heather Jacene, MD Topic: Post PRRT management 

   Speaker: Thomas Hope, MD w/ Panel Topic: Common Challenges 

   Panel Discussion and Audience Participation 

 

Saturday, October 3

9:00 am - 10:00 am EST Virtual Supporter Hall Open

9:00 am - 10:00 am Poster Exhibits Open 

10:00am - 10:40am - Keynote

   Moderator: Pamela Kunz, MD Welcome, Introductory Remarks

   Speaker: James C. Yao, MD

   Audience Participation 

10:45am - 11:40am - NET Medical Session 4: Innovative Approaches to NET Healthcare Delivery 

   Moderator: Jennifer Chan, MD Welcome, Introductory Remarks

   Speaker: Daneng Li, MD Topic: Geriatric issues in NETs

   Speaker: Angela Laffan, NP, MSN Topic: NET Wellness Clinic 

   Speaker: Alia Thawer Topic: Patient centered oral chemo clinic

   Speaker: Sheila Lindsay, NP, MSN Topic: The small NET clinic 

   Audience Participation 

11:45am - 12:25pm - Research Didactic Session: Cutting Edge NET Research

   Moderator: Karine Pozo, PhD Welcome, Introductory Remarks

   Speaker: Chris R. Harris, PhD Topic: Novel mouse models of NETs 

   Speaker: Renata Jaskula-Sztul, PhD Topic: Somatostatin receptor 2 (SSTR2)/ Imaging of alterations in SSTR2 

   Speaker: Lois Mulligan, PhD Topic: RET oncogene and signaling in endocrine tumors

   Audience Participation 

12:30pm - 1:10pm - SIO/ NANETS

   Moderator: Diane Reidy-Lagunes, MD Welcome, Introductory Remarks

   Speaker: Nick Fidelman, MD Patient selection/complications: IAT

   Speaker: Lisa Bodei, MD Patient selection/complications: PRRT 

   Speaker: Michael Soulen, MD Topic: Updates to NCCN guidelines for liver directed therapy for NETs

   Audience Participation 

Meet the Experts | NETworking Break 40 minutes

2:00pm - 2:40pm - Abstracts 2 

Moderator: Daniel Halperin, MD Welcome, Introductory Remarks

Speaker: Thomas Yang Sun, MD - Retrospective analysis of DIPNECH and carcinoid tumorlets progressing to invasive pulmonary carcinoid tumors

Speaker: Sean Bennett, MD - Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity matched comparative population-based analysis

Speaker: Ebrahim Delpassand, MD - 212Pb-AlphaMedixTM Targeted Alpha Therapy (TAT): A potential breakthrough in treatment of metastatic SSTR expressing NET

Speaker: Bassel El-Rayes, MD - Preliminary Safety, PK/PD, and Antitumor Activity of XmAb18087, an SSTR2 x CD3 Bispecific Antibody, in Patients with Advanced Neuroendocrine Tumors

   Audience Participation 

2:45pm - 3:25pm - NET Medical Session 5: Current Controversies in NETS 

   Moderator: Lauren Fishbein, MD, PhD Welcome, Introductory Remarks

   Speaker: Robert Ramirez, DO, FACP Topic: Optimal Adjuvant Therapy in Lung NETs 

   Speaker: Eva Tiensuu Janson MD, PhD" Topic: NET Test 

   Speaker: Xavier Keutgen, MD Univ. of Chicago Topic: Controversies in Surgery for NETs 

   Audience Participation

3:30pm - 4:00pm - Future Directions & Opportunities in NETS (NANETS & ENETS represented) 

   Moderator : Simron Singh, MD, MPH, FRCPC Welcome, Introductory Remarks

   Speakers: James Howe, MD, Emily Bergsland, MD Topic: PANEL DISCUSSION (SS to come up with questions)

   Speaker: Marianne Ellen Pavel, MD, Eva Tiensuu Janson, MD, PhD  PANEL DISCUSSION CONT

   Audience Participation 

4:00 pm - 4:10 pm Closing Remarks - Emily Bergsland, MD